<?xml version="1.0" encoding="UTF-8"?>
<document>
<type>mainstream</type>
<forum>http://www.mideasttime.com/feed</forum>
<forum_title>Mideast Time</forum_title>
<discussion_title>BTG plc (BTG) Stock Rating Reaffirmed by JPMorgan Chase &amp; Co.</discussion_title>
<language>english</language>
<gmt_offset></gmt_offset>
<topic_url>http://www.mideasttime.com/btg-plc-btg-stock-rating-reaffirmed-by-jpmorgan-chase-co/1212584/</topic_url>
<topic_text>
Tweet 
JPMorgan Chase &amp; Co. reissued their neutral rating on shares of BTG plc (LON:BTG) in a research report report published on Tuesday morning. The firm currently has a GBX 790 ($10.17) target price on the stock. 
Shares of BTG plc ( LON:BTG ) opened at 631.00 on Tuesday. The company’s market capitalization is GBX 2.42 billion. BTG plc has a 52-week low of GBX 504.00 and a 52-week high of GBX 739.50. The stock’s 50 day moving average price is GBX 665.21 and its 200-day moving average price is GBX 636.17. 
Other research analysts have also issued research reports about the company. Deutsche Bank AG restated a buy rating and issued a GBX 740 ($9.53) target price on shares of BTG plc in a report on Friday, June 24th. Panmure Gordon reiterated a buy rating and set a GBX 800 ($10.30) price target on shares of BTG plc in a report on Tuesday, May 17th. Jefferies Group reiterated a buy rating and set a GBX 850 ($10.95) price target on shares of BTG plc in a report on Tuesday, May 17th. Stifel Nicolaus reiterated a buy rating on shares of BTG plc in a report on Friday, June 24th. Finally, Numis Securities Ltd reiterated a hold rating and set a GBX 654 ($8.42) price target on shares of BTG plc in a report on Friday, June 24th. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus price target of GBX 753.63 ($9.70). 
In other news, insider Soderstrom,Rolf sold 74,327 shares of BTG plc stock in a transaction on Thursday, July 21st. The stock was sold at an average price of GBX 676 ($8.70), for a total value of £502,450.52 ($646,987.54). Also, insider Makin,Dame Pamela Louise sold 256,404 shares of BTG plc stock in a transaction on Wednesday, July 6th. The shares were sold at an average price of GBX 695 ($8.95), for a total value of £1,782,007.80 ($2,294,627.61). 
BTG plc is a specialist healthcare company. The Company operates in three business segments: Interventional Medicine (IM) (oncology, vascular and pulmonology products), Specialty Pharmaceuticals (antidote products) and Licensing (royalties from licensed assets). The Company’s Interventional Medicine segment offers a portfolio of interventional medicine products that are designed to advance the treatment of liver tumors, advanced emphysema, severe blood clots and varicose veins.   BTG plc   BTG plc  
</topic_text>
<spam_score>0.00</spam_score>
<post_num>1</post_num>
<post_id>post-1</post_id>
<post_url>http://www.mideasttime.com/btg-plc-btg-stock-rating-reaffirmed-by-jpmorgan-chase-co/1212584/</post_url>
<post_date>20160822</post_date>
<post_time>0737</post_time>
<username>Hossein Forouzandeh</username>
<post>
Tweet 
JPMorgan Chase &amp; Co. reissued their neutral rating on shares of BTG plc (LON:BTG) in a research report report published on Tuesday morning. The firm currently has a GBX 790 ($10.17) target price on the stock. 
Shares of BTG plc ( LON:BTG ) opened at 631.00 on Tuesday. The company’s market capitalization is GBX 2.42 billion. BTG plc has a 52-week low of GBX 504.00 and a 52-week high of GBX 739.50. The stock’s 50 day moving average price is GBX 665.21 and its 200-day moving average price is GBX 636.17. 
Other research analysts have also issued research reports about the company. Deutsche Bank AG restated a buy rating and issued a GBX 740 ($9.53) target price on shares of BTG plc in a report on Friday, June 24th. Panmure Gordon reiterated a buy rating and set a GBX 800 ($10.30) price target on shares of BTG plc in a report on Tuesday, May 17th. Jefferies Group reiterated a buy rating and set a GBX 850 ($10.95) price target on shares of BTG plc in a report on Tuesday, May 17th. Stifel Nicolaus reiterated a buy rating on shares of BTG plc in a report on Friday, June 24th. Finally, Numis Securities Ltd reiterated a hold rating and set a GBX 654 ($8.42) price target on shares of BTG plc in a report on Friday, June 24th. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus price target of GBX 753.63 ($9.70). 
In other news, insider Soderstrom,Rolf sold 74,327 shares of BTG plc stock in a transaction on Thursday, July 21st. The stock was sold at an average price of GBX 676 ($8.70), for a total value of £502,450.52 ($646,987.54). Also, insider Makin,Dame Pamela Louise sold 256,404 shares of BTG plc stock in a transaction on Wednesday, July 6th. The shares were sold at an average price of GBX 695 ($8.95), for a total value of £1,782,007.80 ($2,294,627.61). 
BTG plc is a specialist healthcare company. The Company operates in three business segments: Interventional Medicine (IM) (oncology, vascular and pulmonology products), Specialty Pharmaceuticals (antidote products) and Licensing (royalties from licensed assets). The Company’s Interventional Medicine segment offers a portfolio of interventional medicine products that are designed to advance the treatment of liver tumors, advanced emphysema, severe blood clots and varicose veins.   BTG plc   BTG plc  
</post>
<signature>

</signature>
<external_links>

</external_links>
<country>EU</country>
<main_image>http://www.mideasttime.com/logos/btg-logo.jpg</main_image>
</document>
